# LEXISCAN(R) (REGADENOSON)

NDC: 51662-1448
Generic name: LEXISCAN(R) (REGADENOSON)
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20191210

FDA application: NDA022161

## Active ingredients

- REGADENOSON: .08 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1448"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1448
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99640071-4db2-9317-e053-2995a90a610d